The Lancet, 0140-6736

Journal

View graph of relations

Related Publications
  1. Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium

    Multinatl Cardiovasc Risk, 14-Dec-2019, In : LANCET. 394, 10215, p. 2173-2183 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Correspondence: The public health control of scabies: priorities for research and action

    Stienstra, Y., Beeres, D. T., Phillips, R., Vonk, M. & Ravensbergen, S. J., 7-Dec-2019, In : LANCET. 394, 10214, p. 2068 1 p.

    Research output: Contribution to journalLetterAcademicpeer-review

  3. Medical schools should ensure and improve global health education

    de Zeeuw, J., van de Kamp, J. & Browne, J. L., 31-Aug-2019, In : LANCET. 394, 10200, p. 731 1 p.

    Research output: Contribution to journalLetterAcademicpeer-review

  4. Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study

    ASIAN-HF Investigators, Santema, B. T., Ouwerkerk, W., Tromp, J., Sama, I. E., Ravera, A., Regitz-Zagrosek, V., Hillege, H., Samani, N. J., Zannad, F., Dickstein, K., Lang, C. C., Cleland, J. G., Ter Maaten, J. M., Metra, M., Anker, S. D., van der Harst, P., Ng, L. L., van der Meer, P., van Veldhuisen, D. J., Meyer, S., Lam, C. S. P. & Voors, A. A., 5-Oct-2019, In : The Lancet. 394, 10205, p. 1254-1263 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

    SONAR Comm Investigators, 11-May-2019, In : LANCET. 393, 10184, p. 1937-1947 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (526) »

ID: 683330